Background: M. pneumoniae and CARDS toxin interact with respiratory epithelium in the presence of surfactant protein A (SP-A). Objective of the study was to estimate the production of proinflammatory cytokines from human lung epithelial cells activated with M. pneumoniae and CARDS toxin as well as to study the influence of SP-A on M. pneumoniae pathogenicity. Material and Method: SP-A treated and not-treated A549 cells were activated with M. pneumoniae and recombinant CARDS (rCARDS) toxin. TNF-α, IL-6, RANTES and IL-33 were analyzed. Results: Pre-treatment with SP-A enhanced RANTES, TNF-α and IL-6 production and prevented cells from increased release of the allergy associated cytokine IL-33. Conclusion: SP-A regulates the interactio...
Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. Mycoplasma pn...
AbstractThe lung is an organ with a large inner surface that is continuously in contact with the env...
Mycoplasma pneumoniae (Mp) is a leading cause of community acquired pneumonia. Knowledge regarding M...
Surfactant protein-A (SP-A) has well-established functions in reducing bacterial and viral infection...
Mycoplasma pneumoniae infections represent a major primary cause of human respiratory diseases, exac...
Mycoplasma pneumoniae causes a range of airway and extrapulmonary pathologies in humans. Clinically,...
AbstractLipopolysaccharide (LPS) induction of TNF-α release is a central event in the pathophysiolog...
Pneumonia is the leading cause of hospitalization worldwide. Besides viruses, bacterial co-infection...
Mycoplasma pneumoniae causes a range of airway and extrapulmonary pathologies in humans. Clinically,...
Mycoplasma pneumoniae produces an ADP-ribosylating and vacuolating toxin known as the CARDS (Communi...
cidal activity of alveolar macrophages. Am. J. Physiol. 274 (Lung Cell. Mol. Physiol. 18): L270–L277...
Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. Mycoplasma pn...
<div><p>Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. <i>My...
Rationale: Mycoplasma pneumoniae was recently discovered to produce an ADP-ribosylating and vacuolat...
<div><p><i>Mycoplasma pneumoniae</i> causes a range of airway and extrapulmonary pathologies in huma...
Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. Mycoplasma pn...
AbstractThe lung is an organ with a large inner surface that is continuously in contact with the env...
Mycoplasma pneumoniae (Mp) is a leading cause of community acquired pneumonia. Knowledge regarding M...
Surfactant protein-A (SP-A) has well-established functions in reducing bacterial and viral infection...
Mycoplasma pneumoniae infections represent a major primary cause of human respiratory diseases, exac...
Mycoplasma pneumoniae causes a range of airway and extrapulmonary pathologies in humans. Clinically,...
AbstractLipopolysaccharide (LPS) induction of TNF-α release is a central event in the pathophysiolog...
Pneumonia is the leading cause of hospitalization worldwide. Besides viruses, bacterial co-infection...
Mycoplasma pneumoniae causes a range of airway and extrapulmonary pathologies in humans. Clinically,...
Mycoplasma pneumoniae produces an ADP-ribosylating and vacuolating toxin known as the CARDS (Communi...
cidal activity of alveolar macrophages. Am. J. Physiol. 274 (Lung Cell. Mol. Physiol. 18): L270–L277...
Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. Mycoplasma pn...
<div><p>Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. <i>My...
Rationale: Mycoplasma pneumoniae was recently discovered to produce an ADP-ribosylating and vacuolat...
<div><p><i>Mycoplasma pneumoniae</i> causes a range of airway and extrapulmonary pathologies in huma...
Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. Mycoplasma pn...
AbstractThe lung is an organ with a large inner surface that is continuously in contact with the env...
Mycoplasma pneumoniae (Mp) is a leading cause of community acquired pneumonia. Knowledge regarding M...